Obesity Or Overweight

SEP 4, 2026 · PHASE 3 TRIAL

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

ClinicalTrials.gov

This is a Phase 3 registry record with no reported results; the study is actively recruiting and designed to test a combination approach in a dual-disease population, but outcomes remain unreported.

AUG 20, 2026 · PHASE 3 TRIAL

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

ClinicalTrials.gov

This is a registered Phase 3 trial not yet recruiting with no results posted; it describes a planned study design and primary endpoint only.

AUG 14, 2026 · PHASE 3 TRIAL

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

ClinicalTrials.gov

This is an active Phase 3 registry record with no reported results; the study is still recruiting and outcome data are not yet available.

AUG 7, 2026 · PHASE 2 TRIAL

A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight

ClinicalTrials.gov

This is a planned Phase 2 dose-finding trial with no results yet reported; registration documents the study design and population but carries no efficacy or safety data.